Alterity Therapeutics (PRNAD) Non-Current Assets (2009 - 2025)

Alterity Therapeutics (PRNAD) has reported Non-Current Assets for 16 consecutive years, with $62953.8 the latest figure, recorded in Q4 2025.

• In Q4 2025, Non-Current Assets fell 16.83% year-over-year to $62953.8; the TTM figure through Dec 2025 stood at $62953.8 (down 16.83% YoY), while the FY2025 annual figure was $99378.6, down 19.31% from the prior year.
• Non-Current Assets came in at $62953.8 for Q4 2025 at Alterity Therapeutics, down from $99378.6 in the prior quarter.
• The five-year high for Non-Current Assets was $147018.0 in Q2 2024, with the low at $2688.6 in Q2 2023.
• Average Non-Current Assets over 5 years is $85487.0, with a median of $86958.3 recorded in 2024.
• Across the five-year window, Non-Current Assets slumped 97.26% in 2023 and jumped 5368.14% in 2024, its largest moves.
• Year by year, Non-Current Assets stood at $49763.2 in 2021, then surged by 130.58% to $114742.3 in 2022, then advanced by 13.18% to $129861.5 in 2023, then tumbled by 41.71% to $75696.1 in 2024, then fell by 16.83% to $62953.8 in 2025.
• According to Business Quant data, Non-Current Assets over the past three periods registered $62953.8, $99378.6, and $75696.1 for Q4 2025, Q2 2025, and Q4 2024 respectively.